Global RNA Therapeutics Market Highlights
| Market Size (2025) | USD 5.2 Billion |
| Forecast Size (2032) | USD 7.5 Billion |
| CAGR | 5.30% |
| Base Year | 2025 |
| Forecast Period | 2026-2032 |
| Largest Region | North America |
| Fastest Growing Region | Asia |
| Largest Segment | Genetic Disorders |
| Fastest Growing Segment | Auto immune disorders |
| Leading Companies | Moderna, BioNTech, Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Pfizer |
Global RNA Therapeutics Market Size & Growth Rate (2026-2032)
The Global RNA Therapeutics Market was estimated at USD 5.2 Billion in 2025 and is projected to reach USD 7.5 Billion by 2032, growing at a CAGR of 5.30% from 2026 to 2032.
Global RNA Therapeutics Market Synopsis
The Global RNA Therapeutics Market is undergoing transformative changes, driven by increasing innovation in RNA-based therapies and their application across critical therapeutic areas. The approach is gaining traction particularly in addressing genetic disorders, a sector showing a growing pipeline of clinical candidates and enhanced efficacy in treating previously hard-to-manage conditions.
Key advancements include the introduction of mRNA vaccines during the pandemic, showcasing the potential of RNA therapeutics beyond traditional boundaries. Collaborations among biotech firms and research institutions are catalyzing rapid developments, ensuring that the market is not just expanding, but evolving to meet specific unmet medical needs.
Global RNA Therapeutics Market Year-wise Growth Rate and Key Drivers
This graph illustrates the annual growth rates of the Global RNA Therapeutics Market from 2022 to 2032, highlighting a steady upward trajectory and projected expansion over the forecast period.
The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate (%) | Major Drivers |
| 2022 | 5.15 | Supply chain dynamics have constrained the availability of RNA therapeutics components. |
| 2023 | 5.74 | Investing in clinical trial pipelines enhances the development of RNA-based therapies. |
| 2024 | 5.82 | Increased competition among firms ignites advancements in RNA therapeutics innovations. |
| 2025 | 5.01 | Regulators are prioritizing approval processes, accelerating RNA therapeutics market growth. |
| 2026 | 5.2 | Pharmaceutical companies face rising costs for RNA raw materials, affecting pricing strategies. |
| 2027 | 6.15 | Healthcare providers increasingly adopt RNA therapeutics to improve patient outcomes data. |
| 2028 | 5.76 | RNA delivery systems expand globally, enabling wider access to effective therapies. |
| 2029 | 3.78 | A shift toward personalized medicine alters the utilization of RNA therapeutics significantly. |
| 2030 | 3.38 | In the U.S., regulatory changes support the expedited approval of RNA drugs. |
| 2031 | 6.8 | The adoption of telehealth platforms influences how patients receive RNA therapeutic consultations. |
| 2032 | 6.57 | While sustainability concerns rise, RNA therapeutics evolve to meet environmental standards. |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary research methodology, combining internal industry data, secondary research, and primary validation, updated periodically to reflect current market conditions. As markets evolve rapidly, figures for certain industries may vary slightly and are intended as informed estimates rather than absolute figures. For the most current market sizing, we recommend validating figures with a 6Wresearch analyst.
Global RNA Therapeutics Market Key Takeaways
Below are some of the specific key takeaways from the market, including:
- The market for RNA therapeutics is projected to largely be driven by rising investments in mRNA technology, with a reported funding of over USD 10 billion in the last two years alone.
- As of 2025, genetic disorders are projected to comprise approximately ~60% of the market share, positioning it as the leading application segment.
- In 2026, the demand for RNA nanoparticles is expected to grow at a CAGR of 6.5%, closely connected to advances in targeted drug delivery systems.
- The Asia-Pacific region is anticipated to witness a CAGR of 7.2% from 2026 to 2032, fueled by increased healthcare expenditures and growing local biotechnology capabilities.
- Major players like Moderna have identified personalized cancer therapies developed using RNA technology as a key growth area over the next decade.
Evaluation of Restraints in Global RNA Therapeutics Market
Despite considerable growth, the Global RNA Therapeutics Market faces significant challenges, particularly in delivery mechanisms. The inherent instability of RNA compounds limits their effectiveness—estimated loss rates during transport can reach up to 80%. For example, companies like Alnylam Pharmaceuticals have invested millions in developing lipid nanoparticles that can enhance stability and delivery efficiency but face high development and regulatory costs that can amount to approximately USD 200 million per candidate.
Global RNA Therapeutics Market Trends
Several operational and technological trends are reshaping the Global RNA Therapeutics Market landscape. First, there’s a noticeable shift toward personalized medicine, with companies such as BioNTech integrating artificial intelligence into their drug development processes. This approach enables tailored RNA therapies by leveraging patient-specific data to optimize treatment efficacy, dramatically shorting development timelines. For example, as of 2023, BioNTech reported a reduction in clinical trial phases by an average of 25% using AI-directed patient profiling.
Second, automation in manufacturing processes is enhancing throughput and reducing costs associated with RNA drug production. Companies adopting these technologies have seen cost reductions of up to 30%, impacting pricing strategies across marketed products. Additionally, regulatory evolution is also evident, with the FDA approving a new expedited pathway for RNA-based therapies, recognizing their critical role in addressing urgent health needs.
Global RNA Therapeutics Market Opportunities
Looking ahead, the Global RNA Therapeutics Market presents substantial revenue opportunities in various areas. One promising avenue is the integration of RNA therapeutics in vaccine formulations, particularly in combating emerging infectious diseases. For instance, Moderna’s research on universal flu vaccines employing mRNA technology is estimated to have a potential market impact exceeding USD 4 billion by 2030.
Furthermore, collaborations between biotech firms and pharmaceutical giants are expected to lead to breakthroughs in gene editing using RNA interference techniques, with potential market valuations projected to reach USD 2.5 billion by 2027. Such partnerships can leverage shared resources and expertise to accelerate development and reduce time to market.
Global RNA Therapeutics Market by Application
In the Global RNA Therapeutics Market, the dominant application segment is Genetic Disorders, expected to hold a substantial share of approximately ~60% in 2025. This is due to the specificity and targeted approach of RNA molecules in treating conditions like cystic fibrosis and muscular dystrophy. In contrast, Auto immune disorders are identified as the fastest-growing segment, projected to witness a CAGR of 8.2% from 2026 to 2032 as increasing incidences of disorders such as lupus and rheumatoid arthritis stimulate market interest.
Global RNA Therapeutics Market by Route of Administration
In terms of route of administration, Intravenous delivery is the leading method, capturing a substantial share of approximately ~55% in 2025 due to its effectiveness in systemic treatments. However, Intramuscular administration is set to become the fastest-growing segment, expected to experience a CAGR of 9.0% from 2026 to 2032, driven by advances in syringe technology and increased acceptance of intramuscular vaccines resulting from the COVID-19 pandemic.
Global RNA Therapeutics Market by End User
The Global RNA Therapeutics Market is primarily driven by Research Institutes, which are estimated to command an approximate share of ~70% in 2025. This dominance stems from significant funding allocated toward RNA research aimed at discovering novel therapies. Conversely, Hospitals & Clinics are the fastest-growing end-user segment, projected to see a CAGR of 6.8% from 2026 to 2032, paralleling the increasing use of RNA therapies in clinical settings and patient treatment plans.
Global RNA Therapeutics Market by Region
North America stands as the largest region in the Global RNA Therapeutics Market, representing roughly ~48% of the market share in 2025. This position is bolstered by a strong manufacturing ecosystem, considerable investment in R&D, and the presence of leading firms. In contrast, the Asia-Pacific region is poised to be the fastest-growing area, with a projected CAGR of 7.5% from 2026 to 2032. This growth is fueled by expanding healthcare infrastructure and increasing government support for biotech innovations.
Government Initiatives in the Global RNA Therapeutics Market
A robust regulatory environment is instrumental for the growth of the Global RNA Therapeutics Market. Governments worldwide are focused on enabling the development of RNA therapeutic applications through supportive funding and regulatory frameworks designed to streamline approval processes. Recent initiatives illustrate that commitment.
- U.S. Food and Drug Administration (FDA) - Regenerative Medicine Advanced Therapy Designation, 2020: This designation provides a more streamlined process for RNA therapeutics, particularly those for serious conditions, enhancing market entry speed.
- European Medicines Agency (EMA) - PRIME Scheme, 2021: This initiative prioritizes the development of promising RNA therapies and includes guidance on regulatory processes, benefiting companies with greater clarity and support.
- National Institutes of Health (NIH) - Advanced Research Projects Agency for Health (ARPA-H), 2022: With an investment of USD 1.5 billion, this agency focuses on high-risk research in RNA technologies aimed at precision health solutions.
- Japan's Ministry of Health, Labour and Welfare - Clinical Research Network for RNA Therapeutics, 2023: Aiming to advance RNA research collaboration, this initiative fosters partnerships between academia and industry for rapid development of RNA treatments.
Future Insights of the Global RNA Therapeutics Market
By 2032, the Global RNA Therapeutics Market is positioned for transformative structural changes, particularly through advancements in personalized medicine and innovative delivery mechanisms. The growing emphasis on RNA-based solutions, like those from Moderna's universal flu vaccine initiative, aims to address broad healthcare demands, representing a pivotal shift in vaccine technology. Furthermore, investments in biomanufacturing are expected to enhance production capabilities, reducing costs while expanding access, substantiating the increasing interest from government and healthcare sectors in RNA therapies.
Global RNA Therapeutics Market Latest Developments
Recent advancements in the RNA therapeutics sector illustrate the dynamic nature of this industry, with companies pursuing strategic initiatives to solidify their market presence. The following highlights showcase critical developments:
- Moderna recently announced a collaboration with a leading biotech firm to enhance their mRNA platform capabilities, aiming to produce a broader array of RNA therapies by late 2024.
- BioNTech is currently developing an RNA-based treatment for autoimmune diseases, with clinical trials slated to begin in mid-2024, expanding its portfolio beyond oncology.
- Alnylam Pharmaceuticals is enhancing its RNA delivery systems, with a recent investment in novel lipid nanoparticle technologies set to revolutionize therapeutic delivery by early 2025.
- Pfizer is exploring the application of RNA therapeutics in cardiovascular diseases, with plans for an upcoming clinical trial set to launch in late 2023 focused on gene therapies.
Global RNA Therapeutics Market Key Players and Industry Positioning
The Global RNA Therapeutics Market is characterized by a consolidated competitive landscape dominated by a few key players. Companies are leveraging unique capabilities and technologies to secure strategic positions, focusing on diverse therapeutic applications and delivery methodologies.
| Leading Company | Core Strength | Strategic Focus |
|---|---|---|
| Moderna | Advanced mRNA technology platform | Expansion into diverse diseases beyond COVID-19 |
| BioNTech | Expertise in personalized cancer therapies | Broadening applications into infectious and autoimmune diseases |
| Alnylam Pharmaceuticals | Specialization in RNA interference | Enhancing delivery systems for genetic disorders |
| Ionis Pharmaceuticals | Leader in antisense oligonucleotide technology | Development of therapies for rare diseases |
| Pfizer | Strong global presence and R&D capabilities | Focusing on RNA-based vaccine innovations |
As these companies innovate and invest, they will continue shaping the future of RNA therapeutics, enhancing therapeutic outcomes and market competitiveness.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year: 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- Global RNA Therapeutics Market Outlook
- Market Size of Global RNA Therapeutics Market, 2025
- Forecast of Global RNA Therapeutics Market, 2032
- Historical Data and Forecast of Global RNA Therapeutics Revenues & Volume for the Period 2022-2032
- Global RNA Therapeutics Market Trend Evolution
- Global RNA Therapeutics Market Drivers and Challenges
- Global RNA Therapeutics Price Trends
- Global RNA Therapeutics Porter's Five Forces
- Global RNA Therapeutics Industry Life Cycle
- Historical Data and Forecast of Global RNA Therapeutics Market Revenues & Volume
- Historical Data and Forecast of Global RNA Therapeutics Market Revenues & Volume By Application for the Period 2022-2032
- Historical Data and Forecast of Global RNA Therapeutics Market Revenues & Volume By Genetic Disorders for the Period 2022-2032
- Historical Data and Forecast of Global RNA Therapeutics Market Revenues & Volume By Auto immune disorders for the Period 2022-2032
- Historical Data and Forecast of Global RNA Therapeutics Market Revenues & Volume By Route of Administration for the Period 2022-2032
- Historical Data and Forecast of Global RNA Therapeutics Market Revenues & Volume By Intradermal for the Period 2022-2032
- Historical Data and Forecast of Global RNA Therapeutics Market Revenues & Volume By Intramuscular for the Period 2022-2032
- Historical Data and Forecast of Global RNA Therapeutics Market Revenues & Volume By Intravenous for the Period 2022-2032
- Historical Data and Forecast of Global RNA Therapeutics Market Revenues & Volume By End User for the Period 2022-2032
- Historical Data and Forecast of Global RNA Therapeutics Market Revenues & Volume By Research Institutes for the Period 2022-2032
- Historical Data and Forecast of Global RNA Therapeutics Market Revenues & Volume By Hospitals & Clinics for the Period 2022-2032
- Historical Data and Forecast of North America RNA Therapeutics Market Revenues & Volume By Application for the Period 2022-2032
- Historical Data and Forecast of North America RNA Therapeutics Market Revenues & Volume By Genetic Disorders for the Period 2022-2032
- Historical Data and Forecast of North America RNA Therapeutics Market Revenues & Volume By Auto immune disorders for the Period 2022-2032
- Historical Data and Forecast of North America RNA Therapeutics Market Revenues & Volume By Route of Administration for the Period 2022-2032
- Historical Data and Forecast of North America RNA Therapeutics Market Revenues & Volume By Intradermal for the Period 2022-2032
- Historical Data and Forecast of North America RNA Therapeutics Market Revenues & Volume By Intramuscular for the Period 2022-2032
- Historical Data and Forecast of North America RNA Therapeutics Market Revenues & Volume By Intravenous for the Period 2022-2032
- Historical Data and Forecast of North America RNA Therapeutics Market Revenues & Volume By End User for the Period 2022-2032
- Historical Data and Forecast of North America RNA Therapeutics Market Revenues & Volume By Research Institutes for the Period 2022-2032
- Historical Data and Forecast of North America RNA Therapeutics Market Revenues & Volume By Hospitals & Clinics for the Period 2022-2032
- Historical Data and Forecast of United States of America RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Canada RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Rest of North America RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Latin America (LATAM) RNA Therapeutics Market Revenues & Volume By Application for the Period 2022-2032
- Historical Data and Forecast of Latin America (LATAM) RNA Therapeutics Market Revenues & Volume By Genetic Disorders for the Period 2022-2032
- Historical Data and Forecast of Latin America (LATAM) RNA Therapeutics Market Revenues & Volume By Auto immune disorders for the Period 2022-2032
- Historical Data and Forecast of Latin America (LATAM) RNA Therapeutics Market Revenues & Volume By Route of Administration for the Period 2022-2032
- Historical Data and Forecast of Latin America (LATAM) RNA Therapeutics Market Revenues & Volume By Intradermal for the Period 2022-2032
- Historical Data and Forecast of Latin America (LATAM) RNA Therapeutics Market Revenues & Volume By Intramuscular for the Period 2022-2032
- Historical Data and Forecast of Latin America (LATAM) RNA Therapeutics Market Revenues & Volume By Intravenous for the Period 2022-2032
- Historical Data and Forecast of Latin America (LATAM) RNA Therapeutics Market Revenues & Volume By End User for the Period 2022-2032
- Historical Data and Forecast of Latin America (LATAM) RNA Therapeutics Market Revenues & Volume By Research Institutes for the Period 2022-2032
- Historical Data and Forecast of Latin America (LATAM) RNA Therapeutics Market Revenues & Volume By Hospitals & Clinics for the Period 2022-2032
- Historical Data and Forecast of Brazil RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Mexico RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Argentina RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Rest of LATAM RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Asia RNA Therapeutics Market Revenues & Volume By Application for the Period 2022-2032
- Historical Data and Forecast of Asia RNA Therapeutics Market Revenues & Volume By Genetic Disorders for the Period 2022-2032
- Historical Data and Forecast of Asia RNA Therapeutics Market Revenues & Volume By Auto immune disorders for the Period 2022-2032
- Historical Data and Forecast of Asia RNA Therapeutics Market Revenues & Volume By Route of Administration for the Period 2022-2032
- Historical Data and Forecast of Asia RNA Therapeutics Market Revenues & Volume By Intradermal for the Period 2022-2032
- Historical Data and Forecast of Asia RNA Therapeutics Market Revenues & Volume By Intramuscular for the Period 2022-2032
- Historical Data and Forecast of Asia RNA Therapeutics Market Revenues & Volume By Intravenous for the Period 2022-2032
- Historical Data and Forecast of Asia RNA Therapeutics Market Revenues & Volume By End User for the Period 2022-2032
- Historical Data and Forecast of Asia RNA Therapeutics Market Revenues & Volume By Research Institutes for the Period 2022-2032
- Historical Data and Forecast of Asia RNA Therapeutics Market Revenues & Volume By Hospitals & Clinics for the Period 2022-2032
- Historical Data and Forecast of China RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of India RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Japan RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Rest of Asia RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Africa RNA Therapeutics Market Revenues & Volume By Application for the Period 2022-2032
- Historical Data and Forecast of Africa RNA Therapeutics Market Revenues & Volume By Genetic Disorders for the Period 2022-2032
- Historical Data and Forecast of Africa RNA Therapeutics Market Revenues & Volume By Auto immune disorders for the Period 2022-2032
- Historical Data and Forecast of Africa RNA Therapeutics Market Revenues & Volume By Route of Administration for the Period 2022-2032
- Historical Data and Forecast of Africa RNA Therapeutics Market Revenues & Volume By Intradermal for the Period 2022-2032
- Historical Data and Forecast of Africa RNA Therapeutics Market Revenues & Volume By Intramuscular for the Period 2022-2032
- Historical Data and Forecast of Africa RNA Therapeutics Market Revenues & Volume By Intravenous for the Period 2022-2032
- Historical Data and Forecast of Africa RNA Therapeutics Market Revenues & Volume By End User for the Period 2022-2032
- Historical Data and Forecast of Africa RNA Therapeutics Market Revenues & Volume By Research Institutes for the Period 2022-2032
- Historical Data and Forecast of Africa RNA Therapeutics Market Revenues & Volume By Hospitals & Clinics for the Period 2022-2032
- Historical Data and Forecast of South Africa RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Nigeria RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Egypt RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Rest of Africa RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Europe RNA Therapeutics Market Revenues & Volume By Application for the Period 2022-2032
- Historical Data and Forecast of Europe RNA Therapeutics Market Revenues & Volume By Genetic Disorders for the Period 2022-2032
- Historical Data and Forecast of Europe RNA Therapeutics Market Revenues & Volume By Auto immune disorders for the Period 2022-2032
- Historical Data and Forecast of Europe RNA Therapeutics Market Revenues & Volume By Route of Administration for the Period 2022-2032
- Historical Data and Forecast of Europe RNA Therapeutics Market Revenues & Volume By Intradermal for the Period 2022-2032
- Historical Data and Forecast of Europe RNA Therapeutics Market Revenues & Volume By Intramuscular for the Period 2022-2032
- Historical Data and Forecast of Europe RNA Therapeutics Market Revenues & Volume By Intravenous for the Period 2022-2032
- Historical Data and Forecast of Europe RNA Therapeutics Market Revenues & Volume By End User for the Period 2022-2032
- Historical Data and Forecast of Europe RNA Therapeutics Market Revenues & Volume By Research Institutes for the Period 2022-2032
- Historical Data and Forecast of Europe RNA Therapeutics Market Revenues & Volume By Hospitals & Clinics for the Period 2022-2032
- Historical Data and Forecast of United Kingdom RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of France RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Germany RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Rest of Europe RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Middle East RNA Therapeutics Market Revenues & Volume By Application for the Period 2022-2032
- Historical Data and Forecast of Middle East RNA Therapeutics Market Revenues & Volume By Genetic Disorders for the Period 2022-2032
- Historical Data and Forecast of Middle East RNA Therapeutics Market Revenues & Volume By Auto immune disorders for the Period 2022-2032
- Historical Data and Forecast of Middle East RNA Therapeutics Market Revenues & Volume By Route of Administration for the Period 2022-2032
- Historical Data and Forecast of Middle East RNA Therapeutics Market Revenues & Volume By Intradermal for the Period 2022-2032
- Historical Data and Forecast of Middle East RNA Therapeutics Market Revenues & Volume By Intramuscular for the Period 2022-2032
- Historical Data and Forecast of Middle East RNA Therapeutics Market Revenues & Volume By Intravenous for the Period 2022-2032
- Historical Data and Forecast of Middle East RNA Therapeutics Market Revenues & Volume By End User for the Period 2022-2032
- Historical Data and Forecast of Middle East RNA Therapeutics Market Revenues & Volume By Research Institutes for the Period 2022-2032
- Historical Data and Forecast of Middle East RNA Therapeutics Market Revenues & Volume By Hospitals & Clinics for the Period 2022-2032
- Historical Data and Forecast of Saudi Arabia RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of UAE RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Turkey RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Historical Data and Forecast of Rest of Middle East RNA Therapeutics Market Revenues & Volume for the Period 2022-2032
- Global RNA Therapeutics Market - Key Performance Indicators
- Global RNA Therapeutics Market - Import Export Trade Statistics
- Global RNA Therapeutics Market - Opportunity Assessment By Countries
- Global RNA Therapeutics Market - Opportunity Assessment By Application
- Global RNA Therapeutics Market - Opportunity Assessment By Route of Administration
- Global RNA Therapeutics Market - Opportunity Assessment By End User
- Global RNA Therapeutics Market - Top Companies Market Share
- Global RNA Therapeutics Market - Top Companies Profiles
- Global RNA Therapeutics Market - Comparison of Players in Technical and Operating Parameters
- Global RNA Therapeutics Market - Strategic Recommendations
Markets Covered
The Global RNA Therapeutics Market report provides a detailed analysis of the following market segments:
By Regions and Countries:
- North America
- Europe
- LATAM
- Middle East
- Asia
- Africa
By Application:
- Genetic Disorders
- Auto immune disorders
By Route of Administration:
- Intradermal
- Intramuscular
- Intravenous
By End User:
- Research Institutes
- Hospitals & Clinics
